COVID-19 Update | October 2, 2020

COVID-19 News

COVID-19 Update | October 2, 2020

October 2, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of October 2, 2020. Notable advancements include:

  • Regeneron Pharmaceuticals announced early data from its COVID-19 treatment trial showing their antibody drugs decreased viral load and alleviated symptoms faster in non-hospitalized patients.
  • Oxford University said it would study whether the world’s best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients.
  • Johnson & Johnson is slated to begin a COVID-19 vaccine trial in San Diego, with an estimated 2,000 participants at UC San Diego Health.

Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].